@sensible_bio secured $47M in combined financing to scale cell-based mRNA design, screening and clinical-grade manufacturing. dealroom.co/news/159939-sens… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

When the hen is the bioreactor, flock health is process control. Neion Bio engineers hens to make biologic drugs in their eggs. Now it is bringing in Barnwell Bio, whose founders come from COVID wastewater surveillance, to watch the health of its flocks. Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?… "Neion uses chickens to manufacture recombinant proteins. Barnwell provides the intelligence needed to understand and protect the health environment in which those chickens live," says Dimi Kellari, cofounder and CEO of Neion Bio Two #Manhattan biotechs, one unusual partnership. Visit the #SynBioBeta website to read the full article. synbiobeta.com/read/neion-bi…

@bigideaventures is accepting applications for its food-innovation accelerator and direct-investment pathways across food, agtech and sustainable materials. bigideaventures.com/apply-no… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬syntheticbiologysummit.com/?…

@SuntheticsML , @scrippsresearch and @UCLA are using a $19.5M NSF award to build an open-access, closed-loop autonomous chemistry lab. sunthetics.io/blog-posts/nsf… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

Deisseroth, Hegemann and Nagel won the 2026 Nobel Medicine Prize for the discoveries behind light-gated ion channels and optogenetics. apnews.com/article/nobel-pri… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

Xaira reports that X-Design produced progressable antibody leads in weeks, including an antagonist for a GPCR target that resisted prior discovery methods. xaira.com/news/de-novo-desig… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

@CochranLab at @Stanford went looking for a peptide against one cancer target and found one that binds five. Its spinout @TwoStep has now raised $71.2 million and has FDA IND clearance to begin human trials TwoStep Therapeutics grew out of the Stanford labs of #NobelPrize laureate Carolyn Bertozzi and Jennifer Cochran, with oncologist Ronald Levy as a co-founder. Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/?… Its targeting molecule, PIP, is 33 amino acids long. The lab was screening for a binder to one integrin. The peptide that kept winning binds five. "It was a serendipitous discovery." @CaitlynBioE , CEO and co-founder, TwoStep That breadth matters. A tumor needs to express only one of the five for the drug to find it. TwoStep just raised a $62.5M Series A and won FDA IND clearance for TS-104. Visit the SynBioBeta website to read the full article: synbiobeta.com/read/nobel-la…

@theEVERYcompany is expanding OvoPro with Huvepharma and ADM as precision fermentation moves from pilot capacity toward commercial manufacturing. linkedin.com/pulse/what-year… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

PreferCo appointed Shakthi M. Nagappan as CMD as it builds an integrated precision-fermentation platform spanning strain engineering through scale-up. timesofindia.indiatimes.com/… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…

@LonzaGroup and @AsimovBio are combining LV Edge stable producer cells with process development and GMP manufacturing for scalable in vivo lentiviral vectors. asimov.com/news/lonza-and-as… Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬 syntheticbiologysummit.com/?…